Reported about 13 hours ago
Peli BioThermal has expanded its cold chain capabilities through the acquisition of Evo Cold Chain from BioLife Solutions, enhancing its position in cryogenic transport and supporting the rapidly growing cell and gene therapy logistics market. This strategic move is part of a trend in the logistics sector towards consolidation to manage specialized, high-value freight, positioning Peli as a leader in temperature-controlled logistics solutions tailored for the life sciences industry.
Source: YAHOO